LINC02263
gene geneOn this page
Summary
LINC02263 (long intergenic non-protein coding RNA 2263, HGNC:53175) is a long non-coding RNA gene on chromosome 4q26.
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:53175 |
| Approved symbol | LINC02263 |
| Name | long intergenic non-protein coding RNA 2263 |
| Location | 4q26 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000228358 |
| Entrez | 105377390 |
| RNAcentral | URS0000BC4421 — lncRNA, 583 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 0
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
None — 0 exons
Expression profiles
Bgee: expression breadth ubiquitous, 124 present calls, max score 84.05.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2606 / max 143.5361, expressed in 30 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 49411 | 0.1492 | 25 |
| 49408 | 0.0604 | 23 |
| 49410 | 0.0358 | 19 |
| 49409 | 0.0152 | 12 |
Top tissues by expression
124 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| superior frontal gyrus | UBERON:0002661 | 84.05 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 79.40 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 79.01 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.28 | gold quality |
| right frontal lobe | UBERON:0002810 | 78.01 | gold quality |
| frontal cortex | UBERON:0001870 | 76.28 | gold quality |
| prefrontal cortex | UBERON:0000451 | 74.62 | gold quality |
| primary visual cortex | UBERON:0002436 | 73.49 | gold quality |
| cerebral cortex | UBERON:0000956 | 73.11 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 71.26 | gold quality |
| sural nerve | UBERON:0015488 | 70.04 | gold quality |
| testis | UBERON:0000473 | 67.57 | gold quality |
| ventricular zone | UBERON:0003053 | 67.49 | gold quality |
| left testis | UBERON:0004533 | 66.76 | gold quality |
| right testis | UBERON:0004534 | 66.43 | gold quality |
| cortical plate | UBERON:0005343 | 66.12 | gold quality |
| brain | UBERON:0000955 | 62.20 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 61.83 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 60.76 | gold quality |
| ganglionic eminence | UBERON:0004023 | 60.76 | gold quality |
| corpus callosum | UBERON:0002336 | 60.44 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 59.17 | gold quality |
| popliteal artery | UBERON:0002250 | 59.14 | gold quality |
| tibial artery | UBERON:0007610 | 59.13 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 58.37 | gold quality |
| right coronary artery | UBERON:0001625 | 58.26 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 58.20 | gold quality |
| monocyte | CL:0000576 | 58.05 | gold quality |
| duodenum | UBERON:0002114 | 57.96 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 57.61 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.62 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Canonical reviewed UniProt: None (reviewed: )
All UniProt accessions (0):
RefSeq proteins (0): (*=MANE)
Domains & families (InterPro)
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 0 (showing top):
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
0 interactions, top by confidence:
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000093332 (4:117369953 T>A), RS1000525626 (4:117367717 G>T), RS10006701 (4:117369113 C>T), RS1000806517 (4:117367938 T>C), RS1001009194 (4:117361809 T>C), RS1001021835 (4:117361559 C>T), RS1001086486 (4:117365525 G>A), RS1001192323 (4:117361208 A>C), RS1001691521 (4:117366904 T>C), RS1001787449 (4:117360965 C>G,T), RS10018989 (4:117369475 T>A,C,G), RS1002058599 (4:117366615 A>G), RS1002193300 (4:117369196 A>G), RS1002477675 (4:117369497 T>C), RS1002664882 (4:117367887 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 0 entries
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Gold Compounds | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Magnetite Nanoparticles | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.